POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG

Neurology. 2004 Mar 23;62(6):1009-11. doi: 10.1212/01.wnl.0000115386.28769.65.

Abstract

Walker-Warburg syndrome (WWS) is a congenital muscular dystrophy associated with neuronal migration disorder and structural eye abnormalities. The mutations in the O-mannosyltransferase 1 gene (POMT1) were identified recently in 20% of patients with WWS. The authors report on a patient with WWS and a novel POMT1 mutation. Their patient expressed alpha-dystroglycan (alpha-DG) core protein, but fully glycosylated alpha-DG antibody epitopes were absent, associated with the loss of laminin-binding activity.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / genetics
  • Action Potentials
  • Brain / abnormalities*
  • Brain / pathology
  • Child, Preschool
  • Conserved Sequence
  • Creatine Kinase / blood
  • Cytoskeletal Proteins / deficiency
  • Cytoskeletal Proteins / metabolism
  • DNA Mutational Analysis
  • Dystroglycans
  • Electroencephalography
  • Eye Abnormalities / genetics*
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Japan
  • Magnetic Resonance Imaging
  • Male
  • Mannosyltransferases / genetics*
  • Membrane Glycoproteins / deficiency
  • Membrane Glycoproteins / metabolism
  • Muscular Dystrophies / congenital
  • Muscular Dystrophies / genetics*
  • Nervous System Malformations / diagnosis
  • Nervous System Malformations / genetics*
  • Syndrome

Substances

  • Cytoskeletal Proteins
  • DAG1 protein, human
  • Membrane Glycoproteins
  • Dystroglycans
  • Mannosyltransferases
  • protein O-mannosyltransferase
  • Creatine Kinase